Entries by CAPTIS

Mallinckrodt to divest BioVectra for £202m

The deal includes a fixed consideration of $175m (£141m), comprised of an upfront payment of $135 (£109m) and a long-term note for $40m (£32m), as well as contingent The post Mallinckrodt to divest BioVectra for £202m appeared first on Pharmaceutical Business review.

SunGen Pharma receives seventh ANDA approval from US FDA

The seventh approved ANDA is for Fosapreptant for Injection 150mg/vial. This drug product is used for treatment of cyclic vomiting syndrome and late-stage chemotherapy induced vomiting. This is The post SunGen Pharma receives seventh ANDA approval from US FDA appeared first on Pharmaceutical Business review.

Maruho and X-Chem announce drug discovery collaboration

Under the terms of the agreement, X-Chem will utilize its DEX screening platform, which takes advantage of advanced DEX library designs and proprietary informatics tools, to search for The post Maruho and X-Chem announce drug discovery collaboration appeared first on Pharmaceutical Business review.

Endo announces approval of first generic Orfadin in US

Endo’s operating company Par Pharmaceutical, Inc. expects to distribute the product through specialty pharmacies beginning this month. Nitisinone capsules are indicated for the treatment of adult and pediatric The post Endo announces approval of first generic Orfadin in US appeared first on Pharmaceutical Business review.